Uses of CBD in the pharmaceutical industry have increased in recent years. It is currently used in the management of diabetes, anxiety, epilepsy, among other many ailments. Research on the effectiveness of CBD oil on various diseases has intensified.
One of the main focuses is on the use of CBD in treating type 1 and 2 diabetes. Research using both human and animal models has looked at the effects of CBD oil on blood sugar, insulin, inflammation, and neuropathy – pain associated with diabetes. This article will discuss what the research has shown in relation to the use of CBD in treating or alleviating the symptoms of diabetes.
What does the research say on diabetes prevention, inflammation and pain management?
Research has shown mixed results.
Prevention of diabetes
Currently, no research has been conducted using controlled trials to test whether consumption of CBD prevents the development of diabetes. Nevertheless, one study published in the journal of Autoimmunity discovered that nonobese diabetic (NOD) mice showed a low risk of development of diabetes after treatment with CBD oil.
In the past several years, many studies have been conducted to assess the effects of CBD on inflammation. One study on inflammation triggered by high levels of glucose in blood showed that CBD has positive impacts on several markers of inflammation leading to reduced inflammation.
In 2017, a study showing positive effects on pain management using CBD was published in the Journal of Pain. In this research, rats showed reduced inflammation as well as reduced osteoarthritis-associated pain. In a different study published in the Journal of Experimental Medicine, CBD was discovered to depress neuropathic pain in experimental rodents.
Areas in which CBD effectiveness have not been proven
Currently, there is no research evidence to show the effectiveness of CBD in managing blood glucose and HDL cholesterol levels. Nevertheless, research is still going on in these areas.
In a study published in the Journal of Diabetes Care in 2016, researchers found that CBD did not have significant effects on maintaining the ideal HDL cholesterol as well as other important markers such as blood insulin and appetite in individuals with type 2 diabetes.
The main focus of treating diabetes is on how to manage blood sugar levels. Up to today, no research has shown that CBD reduces the levels of blood sugar in diabetic individuals. Patients are advised to use other proven means such as the use of metformin, appropriate diet, and physical exercises.
Although CBD is not harmful to the user, its effectiveness in management must be supported by solid evidence from research. Currently, there seems to be minimum research that has shown its effectiveness, and thus patients should be cautious in using CBD on serious conditions such as diabetes.
They should not discontinue their usual medication to use CBD. In the near future, there is a likelihood that more research will reveal more about CBD in managing diabetes. Until then, CBD should not be used alone in managing diabetes.